Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Zattoni

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
European Urology Oncology|November 29, 2024
The Added Value of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography to Magnetic Resonance Imaging for Local Staging of Prostate Cancer in Patients Undergoing Radical ProstatectomyTimo F W Soeterik, Joris G Heetman, Rick Hermsen, et al.
European Urology Oncology|December 27, 2023
A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate CancerFinbar Slevin, Fabio Zattoni, Enrico Checcucci, et al.
Clinical Genitourinary Cancer|December 28, 2023
The Prognostic Role of Preoperative PSMA PET/CT in cN0M0 pN+ Prostate Cancer: A Multicenter StudyGiancarlo Marra, Pawel Rajwa, Claudia Filippini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 2, 2025
External validation of nomograms including PSMA PET information for the prediction of lymph node involvement of prostate cancerTessa D Van Bergen, Arthur J A T Braat, Rick Hermsen, et al.
BJU International|April 20, 2026
Nodal maximum standardised uptake value improves PSMA-PET/CT-based nodal staging in intermediate- and high-risk prostate cancerAlexandra S Bruins Slot, Vera Sweere, Joris G Heetman, et al.
European Urology Focus|May 10, 2021
Patient- and Tumour-related Prognostic Factors for Urinary Incontinence After Radical Prostatectomy for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysisMichael Lardas, Nikos Grivas, Thomas P A Debray, et al.
European Urology|April 28, 2023
Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic ReviewGiancarlo Marra, Geert J L H van Leenders, Fabio Zattoni, et al.
Journal of the National Cancer Institute|September 26, 2025
Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging-targeted prostate biopsy grade groups are discordantSimone Scuderi, , Amy L Tin, et al.
Prostate Cancer and Prostatic Diseases|January 5, 2024
An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsyAlberto Martini, Lieke Wever, Timo F W Soeterik, et al.
The Journal of Urology|April 13, 2023
Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Study That Challenges the DogmaAlberto Martini, Lieke Wever, Timo F W Soeterik, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
European Urology Oncology|November 29, 2024
The Added Value of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography to Magnetic Resonance Imaging for Local Staging of Prostate Cancer in Patients Undergoing Radical ProstatectomyTimo F W Soeterik, Joris G Heetman, Rick Hermsen, et al.
European Urology Oncology|December 27, 2023
A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate CancerFinbar Slevin, Fabio Zattoni, Enrico Checcucci, et al.
Clinical Genitourinary Cancer|December 28, 2023
The Prognostic Role of Preoperative PSMA PET/CT in cN0M0 pN+ Prostate Cancer: A Multicenter StudyGiancarlo Marra, Pawel Rajwa, Claudia Filippini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 2, 2025
External validation of nomograms including PSMA PET information for the prediction of lymph node involvement of prostate cancerTessa D Van Bergen, Arthur J A T Braat, Rick Hermsen, et al.
BJU International|April 20, 2026
Nodal maximum standardised uptake value improves PSMA-PET/CT-based nodal staging in intermediate- and high-risk prostate cancerAlexandra S Bruins Slot, Vera Sweere, Joris G Heetman, et al.
European Urology Focus|May 10, 2021
Patient- and Tumour-related Prognostic Factors for Urinary Incontinence After Radical Prostatectomy for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysisMichael Lardas, Nikos Grivas, Thomas P A Debray, et al.
European Urology|April 28, 2023
Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic ReviewGiancarlo Marra, Geert J L H van Leenders, Fabio Zattoni, et al.
Journal of the National Cancer Institute|September 26, 2025
Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging-targeted prostate biopsy grade groups are discordantSimone Scuderi, , Amy L Tin, et al.
Prostate Cancer and Prostatic Diseases|January 5, 2024
An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsyAlberto Martini, Lieke Wever, Timo F W Soeterik, et al.
The Journal of Urology|April 13, 2023
Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Study That Challenges the DogmaAlberto Martini, Lieke Wever, Timo F W Soeterik, et al.
Pageof 16